December 11, 2020
December 15, 2020
This newsletter contains BioUtah’s letter to the Department of Health and state leaders, making the case to include employees of Utah’s life sciences companies among priority recipients of COVID-19 vaccines as essential workers. Other news covered includes Utah’s ranking in the Milken Institute 2020 State Technology and Science Index, Gov. Herbert updating Utah’s State Public Health Order, an overview of BioHive, and more.
Recent News
- BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)
- Canary Speech Achieves HITRUST e1 Certification for Voice Biomarker Platform
- Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia
- Denali Therapeutics Announces FDA Acceptance and Priority Review of Biologics License Application (BLA) for Tividenofusp Alfa for Hunter Syndrome (MPS II)
- GE HealthCare’s Economic Impact Across Utah
- RefloDx Wins Trans Atlantic Angel Grand Prize
